PMID- 7532367 OWN - NLM STAT- MEDLINE DCOM- 19950321 LR - 20171213 IS - 0002-9513 (Print) IS - 0002-9513 (Linking) VI - 268 IP - 2 Pt 1 DP - 1995 Feb TI - TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. PG - L173-80 AB - Two distinct mRNA-splice isoforms of tenascin (TN) are expressed differentially during rat lung development. The unique temporal expression pattern of two TN isoforms suggests the expression of tenascin is strictly developmentally regulated in rat lung tissue. We investigated molecular mechanisms which modulate alternative-splicing expression of TN in lung development. The effect of transforming growth factor-beta 1 (TGF-beta 1) on regulation of expression of TN isoforms was examined by in vitro lung explant culture. Immunoblotting with anti-TN antibody detected two TN polypeptides in rat lung explant culture, the larger [relative molecular weight (M(r)) 230, TN230] polypeptide and the smaller (M(r) 180, TN180). TGF-beta 1 markedly induced the TN180 isoform and caused only a moderate increase of the TN230 isoform. The effects of TGF-beta 1 were shown to be dose dependent over a physiological range of TGF-beta 1 protein concentration. The induction of TN isoform biosynthesis by TGF-beta 1 was detected 12 h after addition of the growth factor, and the effects endured for up to 48 h at a dose of 5 ng/ml. By reverse transcriptase-polymerase chain reaction through amplification of the entire fibronectin type III (FN-III) splicing domain, two distinct TN isoforms were detected in total RNA isolated from gestational day 21 rat lung explant culture treated with TGF-beta 1 and from postnatal day 8 rat lung. The larger isoform contained five FN-III alternative splicing repeats [1,420 base pairs (bp)], but the shorter splicing isoform lacked four FN-III alternative splicing repeats (340 bp).(ABSTRACT TRUNCATED AT 250 WORDS) FAU - Zhao, Y AU - Zhao Y AD - Research Service, Durham Department of Veterans Affairs Medical Center, North Carolina 27705. FAU - Young, S L AU - Young SL LA - eng GR - HL-32188/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Physiol JT - The American journal of physiology JID - 0370511 RN - 0 (Cell Adhesion Molecules, Neuronal) RN - 0 (Extracellular Matrix Proteins) RN - 0 (Oligonucleotide Probes) RN - 0 (Tenascin) RN - 0 (Transforming Growth Factor beta) SB - IM MH - *Alternative Splicing MH - Animals MH - Base Sequence MH - Cell Adhesion Molecules, Neuronal/chemistry/*genetics/*metabolism MH - Embryonic and Fetal Development MH - Extracellular Matrix Proteins/chemistry/*genetics/*metabolism MH - Fetus/*metabolism/physiology MH - Isomerism MH - Lung/*embryology MH - Molecular Sequence Data MH - Oligonucleotide Probes/genetics MH - Rats MH - Rats, Sprague-Dawley MH - Tenascin MH - Transforming Growth Factor beta/*pharmacology EDAT- 1995/02/01 00:00 MHDA- 1995/02/01 00:01 CRDT- 1995/02/01 00:00 PHST- 1995/02/01 00:00 [pubmed] PHST- 1995/02/01 00:01 [medline] PHST- 1995/02/01 00:00 [entrez] AID - 10.1152/ajplung.1995.268.2.L173 [doi] PST - ppublish SO - Am J Physiol. 1995 Feb;268(2 Pt 1):L173-80. doi: 10.1152/ajplung.1995.268.2.L173.